Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 300 shares at $191.23 ($57K) on 2020-06-29, disclosed to the SEC on 2020-07-01.
Open-market sale of $57k BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |